Mangiferin alleviates diabetic pulmonary fibrosis in mice via inhibiting endothelial-mesenchymal transition through AMPK/FoxO3/SIRT3 axis

Diabetes mellitus results in numerous complications. Diabetic pulmonary fibrosis (DPF), a late pulmonary complication of diabetes, has not attracted as much attention as diabetic nephropathy and cardiomyopathy. Mangiferin (MF) is a natural small molecular compound that exhibits a variety of pharmaco...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Acta pharmacologica Sinica 2024-05, Vol.45 (5), p.1002-1018
Hauptverfasser:	Fu, Ting-lv, Li, Guo-rui, Li, Dong-hang, He, Ru-yuan, Liu, Bo-hao, Xiong, Rui, Xu, Chen-zhen, Lu, Zi-long, Song, Cong-kuan, Qiu, Hong-liang, Wang, Wen-jie, Zou, Shi-shi, Yi, Ke, Li, Ning, Geng, Qing
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomedical and Life Sciences Biomedicine Immunology Internal Medicine Medical Microbiology Pharmacology/Toxicology Vaccine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!